Literature DB >> 18490736

C5a and TNF-alpha up-regulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome.

Konstantinos Kambas1, Maciej M Markiewski, Ioannis A Pneumatikos, Stavros S Rafail, Vassiliki Theodorou, Dimitrios Konstantonis, Ioannis Kourtzelis, Michael N Doumas, Paola Magotti, Robert A Deangelis, John D Lambris, Konstantinos D Ritis.   

Abstract

Acute respiratory distress syndrome (ARDS) is characterized by the presence of fibrin-rich inflammatory exudates in the intra-alveolar spaces and the extensive migration of neutrophils into alveoli of the lungs. Tissue factor (TF)-dependent procoagulant properties of bronchoalveaolar lavage fluid (BALF) obtained from ARDS patients favor fibrin deposition, and are likely the result of cross-talk between inflammatory mediators and hemostatic mechanisms. However, the regulation of these interactions remains elusive. Prompted by previous findings suggesting that neutrophils, under certain inflammatory conditions, can express functional TF, we investigated the contribution of intra-alveolar neutrophils to the procoagulant properties of BALF from patients with ARDS. Our results confirm that the procoagulant properties of BALF from ARDS patients are the result of TF induction, and further indicate that BALF neutrophils are a main source of TF in intra-alveolar fluid. We also found that BALF neutrophils in these patients express significantly higher levels of TF than peripheral blood neutrophils. These results suggest that the alveolar microenvironment contributes to TF induction in ARDS. Additional experiments indicated that the ability of BALF to induce TF expression in neutrophils from healthy donors can be abolished by inhibiting C5a or TNF-alpha signaling, suggesting a primary role for these inflammatory mediators in the up-regulation of TF in alveolar neutrophils in ARDS. This cross-talk between inflammatory mediators and the induction of TF expression in intra-alveolar neutrophils may be a potential target for novel therapeutic strategies to limit ARDS-associated disturbances of coagulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18490736      PMCID: PMC2673518          DOI: 10.4049/jimmunol.180.11.7368

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes.

Authors:  H Rothberger; T S Zimmerman; H L Spiegelberg; J H Vaughan
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

2.  Structural alterations of lung parenchyma in the adult respiratory distress syndrome.

Authors:  M Bachofen; E R Weibel
Journal:  Clin Chest Med       Date:  1982-01       Impact factor: 2.878

3.  Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia.

Authors:  A C Heflin; K L Brigham
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

4.  Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites.

Authors:  G O Till; K J Johnson; R Kunkel; P A Ward
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

5.  Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis.

Authors:  Elie Azoulay; Sabine Herigault; Micheline Levame; Laurent Brochard; Benoît Schlemmer; Alain Harf; Christophe Delclaux
Journal:  Crit Care Med       Date:  2003-05       Impact factor: 7.598

6.  Ventilation-induced lung injury is associated with an increase in gut permeability.

Authors:  Benoit P Guery; David A Welsh; Nathalie B Viget; Laurent Robriquet; Patrice Fialdes; Carol M Mason; Gilles Beaucaire; Greg J Bagby; Remi Neviere
Journal:  Shock       Date:  2003-06       Impact factor: 3.454

7.  Increased production and expression of tissue thromboplastin-like procoagulant activity in vitro by allogeneically stimulated human leukocytes.

Authors:  H Rothberger; T S Zimmerman; J H Vaughan
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

Review 8.  Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome.

Authors:  Madhav Bhatia; Shabbir Moochhala
Journal:  J Pathol       Date:  2004-02       Impact factor: 7.996

Review 9.  Epidemiology of acute lung injury and acute respiratory distress syndrome.

Authors:  Fernando Frutos-Vivar; Nicolás Nin; Andrés Esteban
Journal:  Curr Opin Crit Care       Date:  2004-02       Impact factor: 3.687

10.  Immune complex-induced human monocyte procoagulant activity. I. a rapid unidirectional lymphocyte-instructed pathway.

Authors:  B S Schwartz; T S Edgington
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

View more
  55 in total

1.  Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.

Authors:  Dennis Chen; Marcos I Restrepo; Michael J Fine; Mary Jo V Pugh; Antonio Anzueto; Mark L Metersky; Brandy Nakashima; Chester Good; Eric M Mortensen
Journal:  Am J Respir Crit Care Med       Date:  2011-04-21       Impact factor: 21.405

2.  Human Neutrophils Support Thrombin Generation in Peritonitis.

Authors:  Souad Lakbakbi; Alexandre Debrumetz; Philippe Rieu; Philippe Nguyen
Journal:  Perit Dial Int       Date:  2015 Sep-Oct       Impact factor: 1.756

Review 3.  Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis.

Authors:  N Maugeri; P Rovere-Querini; M Baldini; M G Sabbadini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2009-03-20       Impact factor: 4.330

4.  A novel C5a-neutralizing mirror-image (l-)aptamer prevents organ failure and improves survival in experimental sepsis.

Authors:  Kai Hoehlig; Christian Maasch; Nelli Shushakova; Klaus Buchner; Markus Huber-Lang; Werner G Purschke; Axel Vater; Sven Klussmann
Journal:  Mol Ther       Date:  2013-07-26       Impact factor: 11.454

Review 5.  Interactions between coagulation and complement--their role in inflammation.

Authors:  Katerina Oikonomopoulou; Daniel Ricklin; Peter A Ward; John D Lambris
Journal:  Semin Immunopathol       Date:  2011-08-03       Impact factor: 9.623

Review 6.  Emerging paradigms in arterial thrombosis.

Authors:  James W Wisler; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

7.  Human mannose-binding lectin inhibitor prevents myocardial injury and arterial thrombogenesis in a novel animal model.

Authors:  Vasile I Pavlov; Ying S Tan; Erin E McClure; Laura R La Bonte; Chenhui Zou; William B Gorsuch; Gregory L Stahl
Journal:  Am J Pathol       Date:  2014-12-04       Impact factor: 4.307

8.  Delayed cerebral thrombosis in bacterial meningitis: a prospective cohort study.

Authors:  Marjolein J Lucas; Matthijs C Brouwer; Diederik van de Beek
Journal:  Intensive Care Med       Date:  2012-12-18       Impact factor: 17.440

Review 9.  Bench-to-bedside review: Association of genetic variation with sepsis.

Authors:  Ainsley M Sutherland; Keith R Walley
Journal:  Crit Care       Date:  2009-04-29       Impact factor: 9.097

10.  Lactobacillus casei modulates the inflammation-coagulation interaction in a pneumococcal pneumonia experimental model.

Authors:  Cecilia Haro; Julio Villena; Hortensia Zelaya; Susana Alvarez; Graciela Agüero
Journal:  J Inflamm (Lond)       Date:  2009-10-16       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.